1818428-14-6
1818428-14-6 structure
- Name: VCE-004.3
- Chemical Name: VCE-004.3
- CAS Number: 1818428-14-6
- Molecular Formula: C26H39NO3
- Molecular Weight: 413.602
- Create Date: 2020-01-20 10:23:55
- Modify Date: 2025-08-25 17:48:37
-
VCE-004.3 (VCE004.3) is a novel semi-synthetic cannabidiol derivative behaving as a dual PPARγ/CB2 agonist and CB1 receptor modulator, binds and activates PPARγ (IC50=3.5 uM) and CB2 receptors (pKi=6.69) and antagonizes CB1 receptor (pKi=5.61); binds to an alternative site at the PPARγ ligand-binding pocket (LBP); VCE-004.3 inhibits collagen gene transcription and synthesis and prevents TGFβ-induced fibroblast migration and differentiation to myofibroblasts; VCE-004.3 prevents skin fibrosis, myofibroblast differentiation and ERK1/2 phosphorylation in bleomycin-induced skin fibrosis; reduces mast cell degranulation, macrophage activation, T lymphocytes infiltration, and the expression of inflammatory and profibrotic factors.
| Name | VCE-004.3 |
|---|
| Description | VCE-004.3 (VCE004.3) is a novel semi-synthetic cannabidiol derivative behaving as a dual PPARγ/CB2 agonist and CB1 receptor modulator, binds and activates PPARγ (IC50=3.5 uM) and CB2 receptors (pKi=6.69) and antagonizes CB1 receptor (pKi=5.61); binds to an alternative site at the PPARγ ligand-binding pocket (LBP); VCE-004.3 inhibits collagen gene transcription and synthesis and prevents TGFβ-induced fibroblast migration and differentiation to myofibroblasts; VCE-004.3 prevents skin fibrosis, myofibroblast differentiation and ERK1/2 phosphorylation in bleomycin-induced skin fibrosis; reduces mast cell degranulation, macrophage activation, T lymphocytes infiltration, and the expression of inflammatory and profibrotic factors. |
|---|---|
| References | References 1. Del Rio C, et al. Br J Pharmacol. 2018 Jul 22. doi: 10.1111/bph.14450. View Related Products by Target Cannabinoid Receptor |
| Molecular Formula | C26H39NO3 |
|---|---|
| Molecular Weight | 413.602 |